Supplementary Figure S3 from A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer
Key Points
Key points are not available for this paper at this time.
Abstract
Supplementary Figure S3. Overall survival in the randomized cohorts.
Like
Bookmark
Share
Like
Bookmark
Share
Supplementary Figure S3 from A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer | Synapse